A highly active and tolerable neoadjuvant regimen combining paclitaxel, carboplatin, 5-FU, and radiation therapy in patients with stage II and III esophageal cancer.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples